Shukra Pharmaceuticals Ltd vs APOLLO HOSPITALS ENTER. L

A side-by-side comparison of Shukra Pharmaceuticals Ltd (524632) and APOLLO HOSPITALS ENTER. L (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads 524632 vs APOLLOHOSP on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation04
  • Profitability40
  • Growth11
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

APOLLOHOSP takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

236.05
P/E ratio
64.89
23.81
P/B ratio
12.55
0.02%
Dividend yield
0.22%
₹0.22
EPS
₹135.04

Profitability

524632 takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

28.90%
Return on equity
21.20%
22.00%
Return on capital
17.00%
39.00%
EBITDA margin
15.00%
30.30%
Net margin
7.94%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-1.31%
Revenue CAGR (3Y)
14.94%
70.51%
Profit CAGR (3Y)
33.39%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2,404 Cr
Market cap
₹1.25L Cr
₹33 Cr
Revenue
₹25,228 Cr
₹10 Cr
Net profit
₹2,003 Cr
0.06
Debt / equity
0.32
Shukra Pharmaceuticals Ltd
  • + ["Company is almost debt free.", "Company is expected to give good quarter", "Company has delivered good profit growth of 175% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 28.2%"]
  • ["Stock is trading at 25.3 times its book value", "Debtor days have increased from 122 to 148 days."]
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
Shukra Pharmaceuticals Ltd full analysis APOLLO HOSPITALS ENTER. L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

524632 vs APOLLOHOSP: Share Price, Valuation & Which to Buy | DocStoX